{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["C/EBP\u03b1", "Lipid metabolism disorder", "PPAR\u03b1", "PPAR\u03b3", "Rubus chingii var. suavissimus", "SREBP1"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34120311", "DateCompleted": {"Year": "2021", "Month": "11", "Day": "25"}, "DateRevised": {"Year": "2021", "Month": "11", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.1007/s11418-021-01536-8"], "Journal": {"ISSN": "1861-0293", "JournalIssue": {"Volume": "75", "Issue": "4", "PubDate": {"Year": "2021", "Month": "Sep"}}, "Title": "Journal of natural medicines", "ISOAbbreviation": "J Nat Med"}, "ArticleTitle": "Rubus chingii var. suavissimus alleviates high-fat diet-induced lipid metabolism disorder via modulation of the PPARs/SREBP pathway in Syrian golden hamsters.", "Pagination": {"StartPage": "884", "EndPage": "892", "MedlinePgn": "884-892"}, "Abstract": {"AbstractText": ["While the underlying mechanism remains unknown, Rubus chingii var. suavissimus (S. K. Lee) L. T. Lu or Rubus suavissimus S. Lee (RS), a sweet plant distributed in southwest of China, has been used as beverage and folk medicine. Pharmacological studies indicated the potential of RS improving the obesity phenotype and hyperlipidemia. The mechanism is still not yet to be put forward. To verify the substantial effects of RS on lipid metabolism, a Syrian golden hamster model was adopted. The physiological and pathological evaluation of experimental animals demonstrated that RS can relieve the lipid metabolism disorder induced by high-fat diet and alleviated liver injury. RS upregulation the expressions of peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1), PPAR\u03b3 and CCAAT/enhancer binding protein \u03b1 (C/EBP\u03b1), as well as adipocyte-specific genes, glucose transporter 4 (Glut4), lipoprotein lipase (LPL) and fatty acid binding protein 4 (aP2). On the other side, RS suppressed the sterol regulatory element binding protein 1 (SREBP1) and downstream acetyl-CoA carboxylase 1 (ACC1), stearoyl-CoA desaturase-1 (SCD1) and fatty acid synthase (FAS). In conclusion, RS alleviated lipid metabolism disorder symptoms caused by high-fat diet accompanied with 8\u00a0weeks of treatment, involving enhanced \u03b2-oxidation, increased adipogenesis and decreased the metabolism of fatty acids, via modulation of the PPARs/SREBP pathway in Syrian golden hamsters."], "CopyrightInformation": "\u00a9 2021. The Japanese Society of Pharmacognosy."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guangxi University of Chinese Medicine, No. 13, Wuhe Avenue, Qingxiu District, Nanning, 530200, Guangxi, China."}], "LastName": "Jiang", "ForeName": "Man-Jing", "Initials": "MJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guangxi University of Chinese Medicine, No. 13, Wuhe Avenue, Qingxiu District, Nanning, 530200, Guangxi, China."}], "LastName": "Li", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guangxi University of Chinese Medicine, No. 13, Wuhe Avenue, Qingxiu District, Nanning, 530200, Guangxi, China."}], "LastName": "Huang", "ForeName": "Wan-Fang", "Initials": "WF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guangxi University of Chinese Medicine, No. 13, Wuhe Avenue, Qingxiu District, Nanning, 530200, Guangxi, China."}], "LastName": "Su", "ForeName": "Jian", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guangxi University of Chinese Medicine, No. 13, Wuhe Avenue, Qingxiu District, Nanning, 530200, Guangxi, China."}], "LastName": "Li", "ForeName": "Yao-Hua", "Initials": "YH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Laboratory of Southwest Endangered Medicinal Resources Development, Guangxi Botanical Garden of Medicinal Plants,, No. 189, Changgang Road, Xingning District, Nanning, 530023, Guangxi, China. quxs@gxyyzwy.com."}], "LastName": "Qu", "ForeName": "Xiao-Sheng", "Initials": "XS"}, {"Identifier": ["0000-0002-1959-8060"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guangxi University of Chinese Medicine, No. 13, Wuhe Avenue, Qingxiu District, Nanning, 530200, Guangxi, China. fanll2015@gxtcmu.edu.cn."}], "LastName": "Fan", "ForeName": "Lan-Lan", "Initials": "LL"}], "GrantList": [{"GrantID": "31660095 and 81903918", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "2019JJA140644", "Agency": "Natural Science Foundation of Guangxi Province", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "J Nat Med", "NlmUniqueID": "101518405", "ISSNLinking": "1340-3443"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "PPAR gamma"}, {"RegistryNumber": "0", "NameOfSubstance": "Sterol Regulatory Element Binding Protein 1"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cricetinae"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Diet, High-Fat"}, {"QualifierName": [], "DescriptorName": "Hyperlipidemias"}, {"QualifierName": [], "DescriptorName": "Lipid Metabolism"}, {"QualifierName": [], "DescriptorName": "Mesocricetus"}, {"QualifierName": ["metabolism"], "DescriptorName": "PPAR gamma"}, {"QualifierName": [], "DescriptorName": "Rubus"}, {"QualifierName": ["genetics"], "DescriptorName": "Sterol Regulatory Element Binding Protein 1"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Li L, Yang GY (2007) Lipid dysmetabolism, adipocytokine and insulin resistance. Chin J Diab 15(3):129\u2013131"}, {"Citation": "Madsen MS, Siersb\u00e6k R, Boergesen M, Nielsen R, Mandrup S (2014) Peroxisome proliferator-activated receptor \u03b3 and C/EBP\u03b1 synergistically activate key metabolic adipocyte genes by assisted loading. Mol Cell Biol 34(6):939\u2013954. https://doi.org/10.1128/MCB.01344-13", "ArticleIdList": ["10.1128/MCB.01344-13", "24379442", "3958030"]}, {"Citation": "Gregoire FM, Fau SC, Sul HS (1998) Understanding adipocyte differentiation. Physiol Rev 78(3):783\u2013809. https://doi.org/10.1152/physrev.1998.78.3.783", "ArticleIdList": ["10.1152/physrev.1998.78.3.783", "9674695"]}, {"Citation": "Darlington GJ, Ross SF, MacDougald OA (1998) The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273(46):30057\u201330060. https://doi.org/10.1074/jbc.273.46.30057", "ArticleIdList": ["10.1074/jbc.273.46.30057", "9804754"]}, {"Citation": "Lin FT, Lane MD (1994) CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 91(19):8757\u20138761. https://doi.org/10.1073/pnas.91.19.8757", "ArticleIdList": ["10.1073/pnas.91.19.8757", "8090719", "44685"]}, {"Citation": "Ding PP, Zhang LY (2019) The role of Peroxisome proliferators-activated receptors \u03b1 in lipid metabolism. Chin J Clin Ration Drug Use. https://doi.org/10.15887/j.cnki.13-1389/r.2019.04.103", "ArticleIdList": ["10.15887/j.cnki.13-1389/r.2019.04.103"]}, {"Citation": "Wang J, Chen H, Sun X, Al E (2019) Research advances in peroxisome proliferator -activated receptor \u03b3 and related diseases. China Mod Med 26(12):36\u201338"}, {"Citation": "Wang ZH, Dong MG, Chang XT, Hou XP (2005) Research progress of fatty acid binding protein and the formation mechanism of hyperlipidemia. Clin Med China 21(04):90\u201391"}, {"Citation": "Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125\u20131131. https://doi.org/10.1172/JCI15593", "ArticleIdList": ["10.1172/JCI15593", "11994399", "150968"]}, {"Citation": "Cui H, Chen LY, Wei HQ, Ning HX, Li YL (2019) Recearch progress on sterol regulatory element-binding proteins inhibitors. Drugs Clin 034(008):2560\u20132566. https://doi.org/10.7501/j.issn.1674-5515.2019.08.066", "ArticleIdList": ["10.7501/j.issn.1674-5515.2019.08.066"]}, {"Citation": "Guangxi Zhuang Autonomous Region Food and Drug Administration (2011) Quality Standard for Zhuang Medicine in Guangxi Zhuang Autonomous Region. Guangxi Science and Technology Press, China"}, {"Citation": "Jeon TI, Osborne TF (2012) SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab Tem. https://doi.org/10.1016/j.tem.2011.10.004", "ArticleIdList": ["10.1016/j.tem.2011.10.004", "22154484"]}, {"Citation": "Wen J, Tuo QH (2011) SREBP affects cell growth by regulating lipid metabolism. Chemistry of Life 31(06):790\u2013795"}, {"Citation": "Xie ZS, Zhao ZB, Zhang ZQ, Al E (2018) Research progress in pharmacology of natural small molecule inhibitors of SREBPs. China Pharm 29(10):1435\u20131440. https://doi.org/10.6039/j.issn.1001-0408.2018.10.34", "ArticleIdList": ["10.6039/j.issn.1001-0408.2018.10.34"]}, {"Citation": "Li SK (1981) Sweet tea, a new Rubus (Rosaceae) from Guangxi. Guihaia 1(4):17\u201319"}, {"Citation": "Wei JF, Huang XC (1996) Identification of original tea plants in Guangxi. J Chin Med Mat 19(1):16\u201317"}, {"Citation": "Ohtani K, Aikawa Y, Kasai R, Chou WH, Yamasaki K, Tanaka O (1992) Minor diterpene glycosides from sweet leaves of Rubus suavissimus. Phytochemistry 31(5):1553\u20131559. https://doi.org/10.1016/0031-9422(92)83105-8", "ArticleIdList": ["10.1016/0031-9422(92)83105-8"]}, {"Citation": "Hirono S, Chou WH, Kasai R, Tanaka O, Tada TJC (1990) Sweet and bitter diterpene-glucosides from leaves of Rubus suavissimus. Chem Pharm Bull 38(6):1743\u20131744. https://doi.org/10.1248/cpb.38.1743", "ArticleIdList": ["10.1248/cpb.38.1743"]}, {"Citation": "Zhang QY (2006) Study on rubusoside and other chemical constituents in leaves of Rubus Suavissimus S.Lee. Guangxi Normal University Master\u00b4s thesis"}, {"Citation": "Chen QB (2005) Separation, purification and determinationof flavone aglycones from Rubus suavissimus. Forest Sci Technol 30(1):46\u201348"}, {"Citation": "Liu J, Zhou X, Weng M, Wang S (2014) The study of pharmacodynamics and mechanism of polyphenols from Rubus suavissimus S. Lee. Pharm Clin Chin Mat Med 30(6):51\u201354"}, {"Citation": "Nordentoft I, Jeppesen PB, Hong J, Abudula R, Hermansen K (2008) Isosteviol increases insulin sensitivity and changes gene expression of key insulin regulatory genes and transcription factors in islets of the diabetic KKAy mouse. Diabetes Obes Metab 10(10):939\u2013949. https://doi.org/10.1111/j.1463-1326.2007.00836.x", "ArticleIdList": ["10.1111/j.1463-1326.2007.00836.x", "18201205"]}, {"Citation": "Wang L, Wei Y, Ning C, Zhang M, Fan P, Lei D, Du J, Gale M, Ma Y, Yang Y (2019) Ellagic acid promotes browning of white adipose tissues in high-fat diet-induced obesity in rats through suppressing white adipocyte maintaining genes. Endocr J 66(10):923\u2013936. https://doi.org/10.1507/endocrj.EJ18-0467", "ArticleIdList": ["10.1507/endocrj.EJ18-0467", "31292308"]}, {"Citation": "Zhang Y, Wang M, Dong H, Yu X, Zhang J (2018) Anti-hypoglycemic and hepatocyte-protective effects of hyperoside from Zanthoxylum bungeanum leaves in mice with high-carbohydrate/high-fat diet and alloxan-induced diabetes. Int J Mol Med 41(1):77\u201386. https://doi.org/10.3892/ijmm.2017.3211", "ArticleIdList": ["10.3892/ijmm.2017.3211", "29115390"]}, {"Citation": "Qin G, Ma J, Huang Q, Yin H, Han J, Li M, Deng Y, Wang B, Hassan W, Shang J (2018) Isoquercetin improves hepatic lipid accumulation by activating AMPK pathway and suppressing TGF-beta signaling on an HFD-induced nonalcoholic fatty liver disease rat model. Int J Mol Sci. https://doi.org/10.3390/ijms19124126", "ArticleIdList": ["10.3390/ijms19124126", "30602689", "6337572"]}, {"Citation": "Kim HM, Kim Y, Lee ES, Huh JH, Chung CH (2018) Caffeic acid ameliorates hepatic steatosis and reduces ER stress in high fat diet-induced obese mice by regulating autophagy. Nutrition 55\u201356:63\u201370. https://doi.org/10.1016/j.nut.2018.03.010", "ArticleIdList": ["10.1016/j.nut.2018.03.010", "29960159"]}, {"Citation": "Wang LL, Zhang ZC, Hassan W, Li Y, Liu J, Shang J (2015) Amelioration of free fatty acid-induced fatty liver by quercetin-3-O-\u03b2-D-glucuronide through modulation of peroxisome proliferator-activated receptor-alpha/sterol regulatory element-binding protein-1c signaling. Hepatol Res 46:225\u2013238. https://doi.org/10.1111/hepr.12557", "ArticleIdList": ["10.1111/hepr.12557", "26190035"]}, {"Citation": "Zhang MF, Shen YQ (2015) Research progress on lipidemic regulation and antiobesity effects of oleanolic acid and ursolic acid. Drug Eval Res 38(1):90\u201397. https://doi.org/10.7501/j.issn.1674-6376.2014.01.018", "ArticleIdList": ["10.7501/j.issn.1674-6376.2014.01.018"]}, {"Citation": "Holvoet P, Rull A, Garc\u00eda-Heredia A, L\u00f3pez-Sanrom\u00e0 S, Geeraert B, Joven J, Camps J (2015) Stevia-derived compounds attenuate the toxic effects of ectopic lipid accumulation in the liver of obese mice: a transcriptomic and metabolomic study. Food Chem Toxicol 77:22\u201333. https://doi.org/10.1016/j.fct.2014.12.017", "ArticleIdList": ["10.1016/j.fct.2014.12.017", "25554529"]}, {"Citation": "Zhang Z, Wang H, Jiao R, Peng C, Wong YM, Yeung VSY, Huang Y, Chen ZY (2009) Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods. Mol Nutr Food Res 53(7):921\u2013930. https://doi.org/10.1002/mnfr.200800517", "ArticleIdList": ["10.1002/mnfr.200800517", "19536872"]}, {"Citation": "D\u00e9cord\u00e9 K, Teiss\u00e8dre PL, Sutra T, Ventura E, Cristol JP, Rouanet JM (2009) Chardonnay grape seed procyanidin extract supplementation prevents high-fat diet-induced obesity in hamsters by improving adipokine imbalance and oxidative stress markers. Mol Nutr Food Res 53(5):659\u2013666. https://doi.org/10.1002/mnfr.200800165", "ArticleIdList": ["10.1002/mnfr.200800165", "19035554"]}, {"Citation": "Ling L, Zhao SP, Cheng YC, Li YL (2003) Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease. Clin Chem 49(8):1347\u20131352. https://doi.org/10.1373/49.8.1347", "ArticleIdList": ["10.1373/49.8.1347"]}, {"Citation": "Guo F, Zi T, Liu L, Feng R, Sun C (2017) A <sup>1</sup>H-NMR based metabolomics study of the intervention effect of mangiferin on hyperlipidemia hamsters induced by a high-fat diet. Food Funct 8(7):2455\u20132464. https://doi.org/10.1039/c7fo00081b", "ArticleIdList": ["10.1039/c7fo00081b", "28617510"]}, {"Citation": "Lv Y, Xu JE (2013) Correlation between PPAR and lipid metabolism in diabetes. J Precis Med 28(03):277\u2013279"}, {"Citation": "Horton JD (2002) Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem Soc Trans 30:1091. https://doi.org/10.1042/bst0301091", "ArticleIdList": ["10.1042/bst0301091", "12440980"]}, {"Citation": "Kotzka J, Knebel B, Avci H, Al E (2010) Phosphorylation of sterol regulatory element-binding protein (SREBP)-1a links growth hormone action to lipid metabolism in hepatocytes. Atherosclerosis 1(213):156\u2013165. https://doi.org/10.1016/j.atherosclerosis.2010.08.046", "ArticleIdList": ["10.1016/j.atherosclerosis.2010.08.046"]}, {"Citation": "Chen Q, Liu MY, Yu HY, Li J, Wang SJ, Zhang Y, Qiu F, Wang T (2018) Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway. J Nat Med 72(3):655\u2013666. https://doi.org/10.1007/s11418-018-1199-5", "ArticleIdList": ["10.1007/s11418-018-1199-5", "29542003"]}, {"Citation": "Padmanaban M, Gopal T, Rajendran AB, Lakshmi BS (2018) Raffinose from Costus speciosus attenuates lipid synthesis through modulation of PPARs/SREBP1c and improves insulin sensitivity through PI3K/AKT. Chem Biol Interact 284:80\u201389. https://doi.org/10.1016/j.cbi.2018.02.011", "ArticleIdList": ["10.1016/j.cbi.2018.02.011"]}, {"Citation": "Shchelkunova TA, Morozov IA, Rubtsov PM, Bobryshev YV, Sobenin IA, Orekhov AN, Andrianova IV, Smirnov AN, Aikawa E (2013) Lipid regulators during atherogenesis: expression of LXR, PPAR, and SREBP mRNA in the human aorta. PLoS ONE. https://doi.org/10.1371/journal.pone.0063374", "ArticleIdList": ["10.1371/journal.pone.0063374", "23717417", "3662660"]}, {"Citation": "Zhang Y, Cui Y, Wang XL, Shang X, Qi ZG, Xue J, Zhao X, Deng M, Xie ML (2015) PPAR\u03b1/\u03b3 agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats. Cytokine 75(1):127\u2013135. https://doi.org/10.1016/j.cyto.2015.05.031", "ArticleIdList": ["10.1016/j.cyto.2015.05.031", "26194065"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "26"}, {"Year": "2021", "Month": "5", "Day": "31"}, {"Year": "2021", "Month": "6", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "13", "Hour": "21", "Minute": "7"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34120311", "10.1007/s11418-021-01536-8", "10.1007/s11418-021-01536-8"]}}], "PubmedBookArticle": []}